Ask AI

Addressing Challenges and Implementing Care Strategies to Optimize BCMA Bispecific Antibody Therapy in RRMM: Expert Insights, Patient Resources, and Adaptive Decision Support

Enhance your understanding of BCMA bispecific antibodies currently used to manage relapsed/refractory multiple myeloma to optimize therapy and improve adherence through an interactive decision support tool, certified interactive case challenge and on-demand webcast, expert-written ClinicalThought commentary, podcast, downloadable resources, and downloadable slides.

Share

Program Content

Activities

RRMM Decision Tool
Optimizing Therapy in Relapsed/Refractory Multiple Myeloma
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: August 07, 2026

Activities

MM BsAb Patient Resource
What I Wish I’d Known Before Starting Bispecific Antibody Therapy for Multiple Myeloma: A Patient Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: November 20, 2025

BsAb AE Resource
Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma: Efficacy and Safety Considerations 
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: January 30, 2026

Activities

BsAb Challenge
Individualizing Therapy for Relapsed/Refractory Multiple Myeloma: Bispecific Antibody Therapy
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: December 31, 2025

Expires: June 30, 2026

Activities

BsAb Therapy in RRMM
Addressing Challenges and Implementing Care Strategies to Optimize BCMA Bispecific Antibody Therapy in RRMM: Expert Insights, Patient Resources, and Adaptive Decision Support
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: January 22, 2026

Activities

BCMA BsAbs in RRMM
Addressing Challenges and Implementing Care Strategies to Optimize BCMA Bispecific Antibody Therapy in RRMM: Expert Insights, Patient Resources, and Adaptive Decision Support
Video
Congratulations: You achieved a completion on 04/09/2022

Released: February 16, 2026

Expires: August 15, 2026

Activities

BsAb Advances in RR MM
Advances in the Use of Bispecific Antibodies for the Treatment of Relapsed/Refractory Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 29, 2026

Activities

BsAbs in RR MM
Oncologists “On Call”: Our Practical Experiences to Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Multiple Myeloma
Podcast
Congratulations: You achieved a completion on 04/09/2022

Released: May 07, 2026

Faculty

cover img faculity

Muhamed Baljevic, MD, FACP

Associate Professor of Medicine, Division of Hematology-Oncology
Director, Multiple Myeloma Program
Director, Vanderbilt Amyloidosis Multidisciplinary Program (VAMP)
Co-Chair, Scientific Review Committee, VICC
Disease Team Lead, Plasma Cell Dyscrasias and Lymphomas
Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University Medical Center
Nashville, Tennessee

cover img faculity

Natalie S. Callander, MD

Director, Myeloma Clinical and Cellular Therapy Program
University of Wisconsin Hospital and Clinics Carbone Cancer Center
Madison, Wisconsin

cover img faculity

Alfred Garfall, MD

Associate Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Perelman School of Medicine, University of Pennsylvania
Philadelphia, Pennsylvania

cover img faculity

Charise Gleason, MSN, NP-C, AOCNP

VP and Chief APP Officer
Emory Healthcare
Nurse Practitioner, Myeloma Program
Winship Cancer Institute
Adjunct Faculty, Nell Hodgson Woodruff School of Nursing
Atlanta, Georgia

cover img faculity

Sarah A. Holstein, MD, PhD

Professor of Medicine
Neumann M. and Mildred E. Harris Professor
Division of Oncology and Hematology
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska

cover img faculity

Carol Ann Huff, MD

Professor of Clinical Oncology and Medicine
Medical Director, Department of Oncology
Division of Hematologic Malignancies, Multiple Myeloma Program
Johns Hopkins University
Baltimore, Maryland

cover img faculity

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Consultant, Division of Hematology
Professor of Medicine
Research Chair, Division of Hematology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Sagar Lonial, MD, FACP, FASCO

Chair and Professor
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

cover img faculity

Jonathan Ticku, MD

Assistant Professor of Oncology, Mayo Clinic
GU Oncology Lead, Mayo Clinic Health System
La Crosse, Wisconsin

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with Smart Patients.

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer Inc.

Partners

Smart Patients

ProCE Banner